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Abstract 
Objective: The objective of this study is to search for Cryptosporidium parvum in Sudanese 
immunocompromised and immunocompetent patients presenting with diarrhea. 
Methods: Two hundred and thirteen stool specimens were collected from different groups of 
patients presenting with diarrhea and healthy control (immunocompromised: 78; 
immunocompetent: 90; Control: 45). 
The immunocompromised group included 25 HIV positive patients, 27 tuberculosis patients, 11 
patients with renal failure and 15 patients receiving immunosuppressive chemotherapy. Antigen 
ELISA was performed to detect the presence of the parasite in stool. 
Positive specimens were examined by the modified ZN stain to look for the oocyst of C.parvum. 
Result: Seventy one of the immunocompromised patients (91.0%), twenty nine of 
immunocompetent patients (32.2 %) and ten of the control group (22.2%) were found to be positive 
for C.parvum. A significant difference was noticed between the immunocompromised patients and 
the other groups (P<0.05). Among the immunocompromised patients, the highest percentage of 
positive results (96.1%) was in the HIV patients. The percentage of positive results within the 
tuberculosis, renal failure and immunosuppressive patients were 92.6%, 83.3% and 86.6% 
respectively. 
Conclusion: The significant detection of C. parvum among the different groups of 
immunocompromised should raise the awareness of the clinicians towards this parasite as an 
important cause of diarrhea in such groups of patients. 
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ryptosporidium parvum (C.parvum) is 
reported as an opportunistic parasite 
that can also cause infection in 
immunocompetent individuals especially 
children¹.  
Serological studies using ELISA showed that 
C.parvum infection is more common in 
developing countries (50-60%) than in 
developed countries (25-30%) 2. 
Infection by C. parvum is more common in 
immunocompromised patients³.  
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Development of symptoms rather slows after 
an incubation period of 2-12 days. In 
immunocmpetent persons infection is usually 
limited to the small intestine while in severely 
immunodifficien patients the biliary tract may 
be involved4. It was reported that 24% of the 
immunocompromised patients with diarrhea 
in developing areas were suffering from 
Cryptosporidiosis5. Large scale surveillance 
for C. parvum is meager and diarrhea due to 
C.parvum may be misdiagnosed due to other 
more common organisms 6.  C. parvum may 
cause asymptomatic or symptomatic acute 
infection of the digestive system in 
immunocompetent patients but it can cause 
life threatening infection in 
immunocompromised patients7. In Sudan, 
data regarding C.parvum infections are 
lacking. Diagnosis of C.parvum infection will 
increase the awareness of the clinician and the 
community about the disease and hence help 
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its control especially among the 
immunocompromised patients. The main 
objective of this study is to assess the 
presence of this parasite among different 
types of patients presenting with diarrhea as 
well as its presence in controls using 
parasitological and ELISA techniques.  
Material and Methods: 
A total number of 213, various age groups 
and sexes were screened for the presence of 
C.parvum during the period May 2009-
February 2010.  
The study was carried out at different sites of 
Khartoum, Omdurman and Khartoum North 
including specialized hospitals for 
immunocompromised patients, clinical 
centers for education and centers for 
immigrants and refugees. Seventy eight of the 
total number were immunocompromised 
patients of different categories (HIV positive: 
25, Tuberculosis patients: 27, renal failure: 11 
and patients under immunosuppressive 
chemotherapy: 15). Ninety immunocompetent 
patients presenting with diarrhea only without 
any other underlying disease were also 
screened for the presence of the parasite. 
Forty five healthy individuals were included 
as a control group. The specimens collected 
were faecal samples. Enzyme linked 
immunosorbant assay, based on the piroplas 
antigen was used to determine the presence of 
C.parvum oocyst antigen in the faecal 
specimens (DRG Instruments GmbH, 
Germany Fraienbergstr. 18, D-35039 
Marburg). 
Formal-ether was used to concentrate the 
parasite and then stained with Modified Ziel 
Neelsen staining technique to visualize the 
oocyst from ELISA positive specimens (Fig 
1)8. The results of the three groups were 
statistically analyzed using the SPSS 
computer program. 
Results:  
Seventy one out of the78 
immunocompromised patients presenting 
with diarrhea were found to be infected by C. 
parvum (91.0%). Ten of the 45 healthy 
controls were found to be positive for C. 
parvum oocyst (22.2%). A significant 
difference was noticed between the 
immunocompromised patients and the healthy 
controls (P<0.05). Twenty nine of the 90 
immunocompetent patients presenting with 




Fig 1: Ziehl Neelsen stained film of C.parvum 
oocysts 
 
No significant difference between the 
immunocompetent patients and the healthy 
controls (P>0.05). 
Twenty four of the HIV patients were positive 
for C. parvum (96.0%). The percentages of 
the positive C. parvum in the groups of 
tuberculosis, renal failure and 
immunosupperessed patients were 92.5%, 




During the past decade C. parvum has been 
recognized worldwide as a human pathogen 
causing a self-limiting infection in 
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immunocompetent patients and a debilitating 
infection in immunocompromised patients9, 
10. This recognition is related to the use of 
more sensitive techniques for the detection of 
the parasite11, 12, 13.  
 
 
Fig. 2: A histogram showing the prevalence 
of Cryptosporidium parvum in different 
immunocompromised groups. 
 
In the present study, the prevalence of C. 
parvum in immunocompromised, 
immunocompetent and control group has 
been evaluated. It was found that the highest 
percentage of infection by the parasite in the 
immunocompromised was in the HIV positive 
patients (96.0%). Similar results were 
reported by Taherkhani et al14. The finding of 
the parasite in 22.2% of the control group 
confirms the fact that the parasite can cause 
asymptomatic infection. On the other hand 
the highly significant percentage of the 
parasite in the immunocompromised patients 
proves its opportunistic character. It has been 
reported that this parasite was responsible for 
some of the severe cases of diarrhea in 
immunosuppressed individuals and can cause 
life threatening infection in HIV patients15, 16. 
In a study of intestinal parasitism in rural and 
urban areas of north central Nigeria, it was 
found that there was increased incidence of 





The detection of C. parvum in the 
immunocompromised Sudanese patients 
presenting with diarrhea in this study should 
increase the clinical vigilance with regard to  
the inclusion of this parasite in the routine 
screening for intestinal parasite especially in 
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